Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heron Therapeutics (HRTX) Other Non-Current Assets (2016 - 2026)

Heron Therapeutics filings provide 16 years of Other Non-Current Assets readings, the most recent being $5.2 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets fell 17.13% to $5.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $5.2 million, a 17.13% decrease, with the full-year FY2025 number at $5.4 million, down 16.58% from a year prior.
  • Other Non-Current Assets hit $5.2 million in Q1 2026 for Heron Therapeutics, down from $5.4 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $18.0 million in Q1 2022 to a low of $5.2 million in Q1 2026.
  • Median Other Non-Current Assets over the past 5 years was $7.9 million (2024), compared with a mean of $9.7 million.
  • Biggest five-year swings in Other Non-Current Assets: surged 5095.66% in 2022 and later tumbled 51.71% in 2023.
  • Heron Therapeutics' Other Non-Current Assets stood at $15.7 million in 2022, then tumbled by 48.27% to $8.1 million in 2023, then fell by 20.24% to $6.5 million in 2024, then decreased by 16.58% to $5.4 million in 2025, then dropped by 3.72% to $5.2 million in 2026.
  • The last three reported values for Other Non-Current Assets were $5.2 million (Q1 2026), $5.4 million (Q4 2025), and $5.9 million (Q3 2025) per Business Quant data.